2. Informed Consent : Must be obtained prior to undergoing any study specific procedures. May be collected more than 28 days prior to study entry. As part of the consenting process, participants will be informed of the potential occurrence of immune related adverse events and will be provided with a Patient Information Card. 3. Tumor History: Will be collected within 28 days prior to study entry. Includes details of primary diagnosis and treatment history. 7. Medical History : Includes history of disease process other than NSCLC (active or resolved), smoking history, and significant concurrent illnes s. Includes prior treatments and any current medical treatment for any condition.